Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype

被引:52
作者
Vinagre, Irene [1 ,2 ]
Luis Sanchez-Quesada, Jose [3 ]
Sanchez-Hernandez, Juan [4 ]
Santos, David [3 ,4 ]
Ordonez-Llanos, Jordi [3 ,5 ,6 ]
De Leiva, Alberto [1 ,7 ]
Perez, Antonio [1 ,4 ]
机构
[1] Hosp Santa Creu & Sant Pau, Endocrinol & Nutr Dept, Barcelona 08025, Spain
[2] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[3] IIB Sant Pau, Biomed Res Inst, Barcelona, Spain
[4] CIBER Diabet & Metab Dis CIBERDEM, Barcelona, Spain
[5] Hosp Santa Creu & Sant Pau, Dept Biochem, Barcelona 08025, Spain
[6] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain
[7] CIBERBBN, Barcelona, Spain
来源
CARDIOVASCULAR DIABETOLOGY | 2014年 / 13卷
关键词
Inflammatory biomarkers; C-reactive protein; Adiponectin; Monocyte chemotactic protein-1; Transforming growth factor-beta(1); Tumor growth factor beta(1); Type; 2; diabetes; LDL phenotype; Atherogenic dyslipidemia; C-REACTIVE PROTEIN; INSULIN-RESISTANCE ATHEROSCLEROSIS; NECROSIS-FACTOR-ALPHA; ACUTE-PHASE PROTEINS; TNF-ALPHA; HYPERTENSIVE PATIENTS; SERUM CONCENTRATIONS; METABOLIC SYNDROME; MESANGIAL CELLS; ELEVATED LEVELS;
D O I
10.1186/1475-2840-13-34
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Type 2 diabetes mellitus (T2D) is associated with higher cardiovascular risk partly related to an increase in inflammatory parameters. The aim of this study was to determine the association of inflammatory biomarkers with low-density lipoprotein (LDL) subfraction phenotype and glycemic control in subjects with T2D and poor glycemic control. Methods: A cross-sectional study was performed comparing 122 subjects with T2D (59 +/- 11 years old, body mass index 30.2 +/- 5.6 kg/m2) with 54 control subjects. Patients with T2D were classified according to their LDL subfraction phenotype and inflammatory biomarkers (C-reactive protein, Interleukin-6, Interleukin-8, Transforming growth factor beta(1), Monocyte chemotactic protein 1, Leptin, Adiponectin) were evaluated according to the degree of glycemic control, LDL phenotype and other clinical characteristics. Forty-two subjects with T2D were studied before and after 3 months of improving glycemic control by different strategies. Results: Patients with T2D had higher C-reactive protein (CRP) and monocyte chemotactic protein-1 (MCP1) levels and lower adiponectin concentration, compared to controls. T2D subjects with body mass index >= 30 kg/m2 had higher CRP levels (5.2 +/- 4.8 mg/l vs 3.7 +/- 4.3 mg/l; p < 0.05). The presence of LDL phenotype B was related to higher levels of transforming growth factor-beta(1) (TGF-beta(1)) (53.92 +/- 52.82 ng/l vs 31.35 +/- 33.74 ng/l; p < 0.05) and lower levels of adiponectin (3663 +/- 3044 ng/l vs 2723 +/- 1776 ng/l; p < 0.05). The reduction of HbA1c from 9.5 +/- 1.8% at baseline to 7.4 +/- 0.8% was associated with a significant reduction of TGF-beta(1) (41.86 +/- 32.84 ng/l vs 26.64 +/- 26.91 ng/l; p = 0.02). Conclusions: Subjects with T2D, especially those with LDL phenotype B and obesity, have higher levels of inflammatory biomarkers. Improvement of glycemic control reduces TGF-beta(1) levels, which may contribute partly to its renoprotective role.
引用
收藏
页数:7
相关论文
共 42 条
[1]  
Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x
[2]   Alterations in plasma transforming growth factor β in normoalbuminuric type 1 and type 2 diabetic patients [J].
Azar, ST ;
Salti, I ;
Zantout, MS ;
Major, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) :4680-4682
[3]   Coronary aspirate TNFα reflects saphenous vein bypass graft restenosis risk in diabetic patients [J].
Baars, Theodor ;
Konorza, Thomas ;
Kahlert, Philipp ;
Moehlenkamp, Stefan ;
Erbel, Raimund ;
Heusch, Gerd ;
Kleinbongard, Petra .
CARDIOVASCULAR DIABETOLOGY, 2013, 12
[4]   A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change [J].
Belalcazar, L. Maria ;
Reboussin, David M. ;
Haffner, Steven M. ;
Hoogeveen, Ron C. ;
Kriska, Andrea M. ;
Schwenke, Dawn C. ;
Tracy, Russell P. ;
Pi-Sunyer, F. Xavier ;
Ballantyne, Christie M. .
DIABETES CARE, 2010, 33 (11) :2297-2303
[5]   Inflammation and the Incidence of Type 2 Diabetes The Multi-Ethnic Study of Atherosclerosis (MESA) [J].
Bertoni, Alain G. ;
Burke, Gregory L. ;
Owusu, James A. ;
Carnethon, Mercedes R. ;
Vaidya, Dhananjay ;
Barr, R. Graham ;
Jenny, Nancy S. ;
Ouyang, Pamela ;
Rotter, Jerome I. .
DIABETES CARE, 2010, 33 (04) :804-810
[6]   Inflammation and type 2 diabetes [J].
Calle, M. C. ;
Fernandez, M. L. .
DIABETES & METABOLISM, 2012, 38 (03) :183-191
[7]   The need for early predictors of diabetic nephropathy risk - Is albumin excretion rate sufficient? [J].
Caramori, ML ;
Fioretto, P ;
Mauer, M .
DIABETES, 2000, 49 (09) :1399-1408
[8]  
Di BE, 2013, J BIOL CHEM
[9]  
ESCHWEGE E, 2003, DIABETES METAB 2, V29
[10]   Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes - The insulin resistance atherosclerosis study [J].
Festa, A ;
D'Agostino, R ;
Tracy, RP ;
Haffner, SM .
DIABETES, 2002, 51 (04) :1131-1137